SPONSOR
OSE Immunotherapeutics
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2, Phase 3
Conditions studied: Solid Advanced TumorLymphomaNSCLC (Non-small Cell Lung Cancer)Patients With Non-Small Cell Lung Cancer
OSE Immunotherapeutics is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer), Patients With Non-Small Cell Lung Cancer.
The trial portfolio spans Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — OSE Immunotherapeutics
How many clinical trials has OSE Immunotherapeutics sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by OSE Immunotherapeutics, of which 2 are actively recruiting participants. These trials cover conditions including Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does OSE Immunotherapeutics research focus on?
OSE Immunotherapeutics clinical trials span Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer), Patients With Non-Small Cell Lung Cancer. The research pipeline includes Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a OSE Immunotherapeutics clinical trial?
To participate in a OSE Immunotherapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all OSE Immunotherapeutics trials with current recruitment status updated daily.
Clinical Trials by OSE Immunotherapeutics
NCT05751798 Phase 1, Phase 2
Recruiting
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
Solid Advanced Tumor
NCT06472245 Phase 3
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Patients With Non-Small Cell Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology